Trial intelligence / Profile preview

Dextrose Injections for Stage IV Knee Osteoarthritis

NCT01210183Phase 3Completed

Sponsor
Universidad Nacional de Rosario
Start
Jul 2010
Primary completion
Dec 2013
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of dextrose in knee osteoarthritis (OA), sponsored by Universidad Nacional de Rosario. Primary endpoints: Quality of cartilage growth and Number of sections of medial condyle with loss, no change or growth of cartilage at 7.5 months. Started Jul 2010; status: completed.

02

Drugs

dextrose
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01210183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01210183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call